Study for People Living with Parkinson's Disease

Study 1143

We are looking for people with Parkinson's disease to participate in a clinical trial of an experimental drug for the disease.

The purpose of the study is to investigate the drug’s safety and tolerability, as well as how it is absorbed, distributed, and excreted in the body. 

The study consists of nine visits to our clinic in Uppsala.

Target group: people with Parkinson's disease 

Criteria for participation:

• Have been diagnosed with Parkinson's disease  

• Be on stable treatment with levodopa alone, or levodopa in combination with dopamine agonists 

• Must not have participated in another drug study in the last three months 

More information and registration

Would you like to participate in the study?Please submit an expression of interest using the form below.

Do you have any questions or want to know more?Call 018-30 33 99 or emailinfo@ctc-ab.se.

The study has been approved by the Swedish Ethical Review Authority and the Swedish Medical Products Agency. Your participation is voluntary, and you may withdraw at any time. The information you provide will be processed in accordance with the General Data Protection Regulation (GDPR).

Sign up here